Emerald Health Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was CAD 3.044 million compared to CAD 2.481 million a year ago. Operating loss was CAD 4.412 million compared to CAD 2.459 million a year ago. Net loss was CAD 13.956 million compared to CAD 18.862 million a year ago. Basic loss per share from continuing operations was CAD 0.07 compared to CAD 0.1 a year ago. For the half year, total revenue was CAD 5.299 million compared to CAD 5.370 million a year ago. Operating loss was CAD 8.939 million compared to CAD 9.328 million a year ago. Net loss was CAD 16.856 million compared to CAD 23.596 million a year ago. Basic loss per share from continuing operations was CAD 0.08 compared to CAD 0.13 a year ago.